Microba Life Sciences Limited (ASX: MAP) ("Microba") a precision microbiome company, today announces two significant ...

TNF Indicates Likelihood of Patient Response to Costly IBD Treatment Before Initiation of Therapy SAN DIEGO, CA / ACCESS ...

Aris Water Solutions stock earns the No. 1 rank among its peers in the Pollution-Control industry group. GFL Environmental ...

Experts warn that US President Trump's escalating trade war with China is set to significantly impact American businesses and ...

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...

At the end of Q4 2024, 18 billionaires held positions in Johnson & Johnson (NYSE:JNJ), worth over $2.9 billion collectively.

AbbVie Inc. reports a strong Q1 2025 with EPS of $2.46 and raised guidance, fueled by Skyrizi, Rinvoq, and neuroscience growth.

Ameriprise is offering up to 125% of trailing revenue to reel in top-producing Commonwealth advisors from LPL as a recruiting ...

CEO Ritik Malhotra is leveraging Savvy Wealth's Fidelity partnership in offers to Commonwealth advisors, alongside ...